As demand for medicinal cannabis soars in the UK, Dalgety, a new company, has established a high-security factory to cultivate and sell the drug directly to pharmacies. Founders James Leavesley and Brady Green work alongside a dedicated team to turn a significant investment into a facility capable of producing up to 4,000 prescriptions each month. Despite the challenges of regulatory licenses, they aim to revolutionize the market while addressing the stigma and accessibility issues surrounding legal cannabis use.